Gammaherpesviruses are oncogenic pathogens that establish lifelong infections. There are no FDA-approved vaccines against Epstein–Barr virus or Kaposi sarcoma herpesvirus.
Dipanwita Mitra +3 more
doaj +1 more source
Mathematical modeling and mechanisms of HIV latency for personalized anti latency therapies
Combination antiretroviral therapy controls human immunodeficiency virus-1 (HIV) but cannot eradicate latent proviruses in immune cells, which reactivate upon treatment interruption.
Gianmarco Rasi +4 more
doaj +1 more source
Different expression pattern of human cytomegalovirus-encoded microRNAs in circulation from virus latency to reactivation. [PDF]
Zhou W +8 more
europepmc +1 more source
Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection. [PDF]
Inagaki T +11 more
europepmc +1 more source
STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency. [PDF]
Wang Y +13 more
europepmc +1 more source
Arginine metabolism supports <i>de novo</i> pyrimidine biosynthesis to block DNA damage and maintain Epstein-Barr virus latency. [PDF]
White S +6 more
europepmc +1 more source
Relationship satisfaction determines the association between Epstein-Barr virus latency and somatic symptoms after the loss of a spouse. [PDF]
LeRoy AS +6 more
europepmc +1 more source
Lytic promoter activity during herpes simplex virus latency is dependent on genome location. [PDF]
Singh N +3 more
europepmc +1 more source
Novel Transmitted/Founder Simian-Human Immunodeficiency Viruses for Human Immunodeficiency Virus Latency and Cure Research. [PDF]
Bauer AM +10 more
europepmc +1 more source
Is Epstein Barr virus latency protective against type 1 diabetes? [PDF]
Zoledziewska M.
europepmc +1 more source

